| Product Code: ETC7652713 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
In 2024, Israel continued to import gram-positive bacterial infection treatments from Switzerland, UK, Belgium, Germany, and the USA. The market concentration, as measured by the Herfindahl-Hirschman Index (HHI), remained low, indicating a diverse range of sources. Despite a slight decline in the compound annual growth rate (CAGR) from 2020-2024 at -2.08%, the market showed some resilience with a moderate growth rate of -1.07% in 2023-24. This suggests a stable market for gram-positive bacterial infection treatments in Israel with steady contributions from key exporting countries.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Gram-positive Bacterial Infections Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Gram-positive Bacterial Infections Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Gram-positive Bacterial Infections Market - Industry Life Cycle |
3.4 Israel Gram-positive Bacterial Infections Market - Porter's Five Forces |
3.5 Israel Gram-positive Bacterial Infections Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Israel Gram-positive Bacterial Infections Market Revenues & Volume Share, By Disease, 2021 & 2031F |
3.7 Israel Gram-positive Bacterial Infections Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Israel Gram-positive Bacterial Infections Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Gram-positive Bacterial Infections Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of gram-positive bacterial infections in Israel |
4.2.2 Growing awareness about the importance of appropriate antibiotic use |
4.2.3 Technological advancements in diagnostic techniques for gram-positive bacterial infections |
4.3 Market Restraints |
4.3.1 Rising antibiotic resistance among gram-positive bacteria |
4.3.2 Stringent regulations for antibiotic approvals and usage in Israel |
5 Israel Gram-positive Bacterial Infections Market Trends |
6 Israel Gram-positive Bacterial Infections Market, By Types |
6.1 Israel Gram-positive Bacterial Infections Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Gram-positive Bacterial Infections Market Revenues & Volume, By Drug Type, 2021- 2031F |
6.1.3 Israel Gram-positive Bacterial Infections Market Revenues & Volume, By Antibiotic, 2021- 2031F |
6.1.4 Israel Gram-positive Bacterial Infections Market Revenues & Volume, By Antifungal, 2021- 2031F |
6.1.5 Israel Gram-positive Bacterial Infections Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Israel Gram-positive Bacterial Infections Market, By Disease |
6.2.1 Overview and Analysis |
6.2.2 Israel Gram-positive Bacterial Infections Market Revenues & Volume, By MRSA, 2021- 2031F |
6.2.3 Israel Gram-positive Bacterial Infections Market Revenues & Volume, By Pneumonia, 2021- 2031F |
6.2.4 Israel Gram-positive Bacterial Infections Market Revenues & Volume, By Sepsis, 2021- 2031F |
6.2.5 Israel Gram-positive Bacterial Infections Market Revenues & Volume, By Sinusitis, 2021- 2031F |
6.2.6 Israel Gram-positive Bacterial Infections Market Revenues & Volume, By Cellulitis, 2021- 2031F |
6.2.7 Israel Gram-positive Bacterial Infections Market Revenues & Volume, By Otitis, 2021- 2031F |
6.3 Israel Gram-positive Bacterial Infections Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Israel Gram-positive Bacterial Infections Market Revenues & Volume, By Enteral, 2021- 2031F |
6.3.3 Israel Gram-positive Bacterial Infections Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.4 Israel Gram-positive Bacterial Infections Market Revenues & Volume, By Others (Topical, Transdermal), 2021- 2031F |
6.4 Israel Gram-positive Bacterial Infections Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Israel Gram-positive Bacterial Infections Market Revenues & Volume, By Hospitals Pharmacies, 2021- 2031F |
6.4.3 Israel Gram-positive Bacterial Infections Market Revenues & Volume, By Drug Stores and Retail Pharmacies, 2021- 2031F |
6.4.4 Israel Gram-positive Bacterial Infections Market Revenues & Volume, By Others, 2021- 2031F |
7 Israel Gram-positive Bacterial Infections Market Import-Export Trade Statistics |
7.1 Israel Gram-positive Bacterial Infections Market Export to Major Countries |
7.2 Israel Gram-positive Bacterial Infections Market Imports from Major Countries |
8 Israel Gram-positive Bacterial Infections Market Key Performance Indicators |
8.1 Rate of antibiotic resistance development among gram-positive bacteria |
8.2 Adoption rate of advanced diagnostic techniques for gram-positive bacterial infections |
8.3 Number of research and development initiatives focused on novel antibiotics targeting gram-positive bacteria |
9 Israel Gram-positive Bacterial Infections Market - Opportunity Assessment |
9.1 Israel Gram-positive Bacterial Infections Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Israel Gram-positive Bacterial Infections Market Opportunity Assessment, By Disease, 2021 & 2031F |
9.3 Israel Gram-positive Bacterial Infections Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Israel Gram-positive Bacterial Infections Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Gram-positive Bacterial Infections Market - Competitive Landscape |
10.1 Israel Gram-positive Bacterial Infections Market Revenue Share, By Companies, 2024 |
10.2 Israel Gram-positive Bacterial Infections Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |